BRAF and borderline ovarian serous tumor: The most common recurrent mutations identified in LGSOC and its putative precursor, serous borderline ovarian tumor (SBOT), are BRAF and KRAS. BRAF and KRAS mutations have been identified in approximately 60% of SBOTs and early stage LGSOCs [5–9].